Filing Details

Accession Number:
0001209191-14-072478
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-02 18:42:52
Reporting Period:
2014-12-02
Filing Date:
2014-12-02
Accepted Time:
2014-12-02 18:42:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1517022 Akebia Therapeutics Inc. AKBA Pharmaceutical Preparations (2834) 208756903
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1354434 Jr C Ronald Renaud C/O Akebia Therapeutics, Inc.
245 First Street, Suite 1100
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-02 5,000 $11.92 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in this Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.85 to $11.95, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.